A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03233295

Enrollment

108

Registered

2017-07-28

Start date

2014-10-23

Completion date

2016-08-27

Last updated

2017-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D Deficiency

Brief summary

A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in adults with Vitamin D Deficiency

Interventions

DRUGVitamin D3 B.O.N. Injection

cholecalciferol 200,000IU

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

19 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Subjects with vitamin D deficiency

Exclusion criteria

* Subjects who experienced a hypersensitivity to the cholecalciferol * Subjects with Hypercalcemia * Subjects with Hypercalciuria * Subjects with renal impairment * Subjects with calcium stone * Subjects diagnosed with sarcoidosis or pseudo-hypoparathyroidism * Subjects who are to take vitamin D supplements during the study period

Design outcomes

Primary

Measure	Time frame
serum 25(OH)D concentration	12 months

Secondary

Measure	Time frame
serum 1,25(OH)2D concentration	12 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026